For treatment purposes, MCACL has been traditionally considered a non-small cell lung carcinoma (NSCLC). Complete radical surgical resection is the treatment of choice. There is virtually no data regarding new molecular targets or targeted therapy in the literature to date. Iwasaki and co-workers failed to find mutations of the epidermal growth factor receptor (EGFR) or the cellular Kirsten rat sarcoma virus oncogene K-ras in one reported case.
Mucinous cystadenocarcinoma of the lung
Epithelial-myoepithelial carcinoma of the lung
Atypical pulmonary carcinoid tumour
Salivary gland–like carcinoma of the lung
Large cell neuroendocrine carcinoma of the lung
Giant-cell carcinoma of the lung
Sarcomatoid carcinoma of the lung
Basaloid large cell carcinoma of the lung